News & Analysis on Clinical Trial Services & Contract Research And Development
Fisher Scientific subsidiary Perbio last week opened a new facility in the UK to manufacture its Hyclone range of cell culture equipment and mediathat ramps up its liquid production capacity by a factor of four, reports Phil Taylor.
In the build up to the American Society of Clinical Oncology's (ASCO) annual conference, drug companies from around the world have been showcasing potential drug treatments, with a number of new molecular targets for cancer, writes Wai Lang Chu.
It has been eight years since Molecular Devices first introduced its FLIPR (Fluorometric Imaging Plate Reader) onto the market to answer the need for a detection device that could handle cells.